Rashtriya Newsflash

Anti-CD152 Antibody Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Precision Biosciences, TG Therapeutics, RemeGen, Caribou Biosciences

Anti-CD152 Antibody Pipeline 2025: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Precision Biosciences, TG Therapeutics, RemeGen, Caribou Biosciences

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Anti-CD152 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD152 Antibody treatment therapies, analysis of Clinical Trials, Therapies, Mechanism

Read Full Article

Crispr Therapeutics Products 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | eGenesis, Intellia Therapeutics, Editas Medicine, Caribou Biosciences, Inscripta, Synthego

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, CRISPR Therapies pipeline constitutes 25+ key companies continuously working towards developing 30+ CRISPR Therapies treatment therapies, analysis of Clinical Trials,

Read Full Article

Global Cataract Surgery Devices Market to grow at a CAGR of 5.50% by 2030, Evaluates DelveInsight | Alcon, Johnson & Johnson, NIDEK, ZEISS Group, Bausch Health, Ziemer Ophthalmic Systems AG, Abbott

Key Cataract Surgery Devices companies operating in the market include- Alcon Inc., Johnson & Johnson Services, Inc., NIDEK CO., LTD., ZEISS Group, Bausch Health Companies Inc., Ziemer Ophthalmic Systems AG,

Read Full Article

Acquired Hemophilia A Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Novo Nordisk, Sanofi, Pfizer, Belief BioMed, Centessa Pharmaceuticals

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Acquired Hemophilia A pipeline constitutes 10+ key companies continuously working towards developing 10+ Acquired Hemophilia A treatment therapies, analysis of

Read Full Article

Anticoagulants Market Statistics Expected to Experience Major Growth by 2032, According to DelveInsight | Takeshi Morimoto, Prothya BioSolutions, ARYx Therapeutics, Les Laboratoires

The Key Anticoagulants Companies in the market include – Universitaire Ziekenhuizen KU Leuven, Takeshi Morimoto, Prothya BioSolutions, ARYx Therapeutics, Les

Read Full Article

Anemia in Chronic Kidney Disease Market Set for Significant Growth and Innovation by 2034 | Says DelveInsight

Anemia in Chronic Kidney Disease Market Anemia in Chronic Kidney Disease (CKD), a common and debilitating complication resulting from reduced

Read Full Article

Venous Leg Ulcer Market Set to Evolve with Advancements in Wound Care and Rising Patient Burden by 2034 | Says DelveInsight

Venous Leg Ulcer Market Venous Leg Ulcer (VLU), the most common chronic lower limb ulcer, presents major clinical and economic

Read Full Article

Acute Myocardial Infarction Market to Evolve with Novel Therapies and Strategic Advancements by 2034 | Forecasts DelveInsight

Acute Myocardial Infarction Market The Acute Myocardial Infarction (AMI) market is undergoing transformative change, spurred by advancements in rapid diagnostic

Read Full Article

Restrictive Cardiomyopathy Market Set for Transformative Developments and Rising Demand by 2034 | Says DelveInsight

Restrictive Cardiomyopathy (RCM), a rare and complex form of cardiomyopathy, is gaining increased attention from researchers and biopharma developers. DelveInsight’s

Read Full Article

Coagulation Factor Deficiency Market to Witness Significant Innovation and Growth by 2034 | Predicts DelveInsight

Coagulation Factor Deficiency Market The Coagulation Factor Deficiency market is evolving rapidly, fueled by advances in gene therapy, long-acting clotting

Read Full Article